Team:Penn/SurfaceDisplay

From 2012.igem.org

(Difference between revisions)

Revision as of 21:05, 26 October 2012

Penn 2012 iGEM Wiki

Displaying an Engineered Cancer Cell Binder on the Outer Membrane Surface

Having demonstrated that our INPNC surface display system could localize a desired protein (mCherry) to the outer membrane surface, we sought to display the picomolar affinity, HER2 binding Designed Ankyrin Repeat Protein (DARPin) H10-2-G3 on the surface of our BL21 cells. This would allow for bacterial targeting to HER2 over-expressing cells, that could then be lysed in a spatially accurate manner using our light-activated ClyA expression system. Such surface display of a large antibody-mimetic protein is unprecedented, and assaying whether it had actually occurred would be difficult.

We constructed a C-terminal INPNC-DARPin fusion in the same manner as our INPNC-mCherry fusion, except we added a Human Influenza Aggregation (HA) tag to the N-terminal of DARPin to allow us to use antibodies to assay whether it had been localized to the membrane. After expression and 48-hour induction of INPNC-DARPin-HA in BL21 cells using the pET26b expression vector, we immunostained cells using an anti-HA, Alexa-fluor 647 conjugated antibody (Cell Signaling Technologies). Since antibodies are not permeable to the E. coli membrane, after washing the cells there should be signal only on those cells that have displayed the HA tag on their surface. We attempted to assay these stained cells with flow cytometry, but soon realized that we required much higher-resolution FACS sorting equipment than we had available to count bacteria.

We then took a small amount of HA immunostained bacteria and visualized them by confocal microscopy at high (630x) magnification using a 633 He-Ne laser. Using this immunostaining visualization method, we were able to demonstrate for the first time that DARPin H10-2-G3 had in fact been localized to the cell surface (Figures 2-9).

We first stained control bacteria expressing DARPin-HA without fusion to INPNC (Figures 2-3). The following images were taken of identical densities of bacteria as verified by phase contrast.

Figure 2

Figure 2: Uninduced pET26b-DARPin-HA (-IPTG) bacteria are not immunostained by anti-HA antibody.

Figure 3

Figure 3: Induced pET26b-DARPin-HA (+IPTG) bacteria are not immunostained by anti-HA antibody.

Then, to determine whether INPNC could display an HA tag on the surface of E. coli, we stained bacteria expressing INPNC-HA and found that IPTG-induced bacteria exhibited strong red fluorescence when excited by the 633nm laser (Figures 4-5).

Figure 4

Figure 4: Uninduced pET26b-INPNC-HA (-IPTG) bacteria are not immunostained by anti-HA antibody.

Figure 5

Figure 5: Induced pET26b-INPNC-HA (+IPTG) bacteria are strongly immunostained by anti-HA antibody, indicating surface expression.

Finally, to determine whether we could display our HA-tagged DARPin on the surface of E. coli, we stained INPNC-DARPin-HA expressing bacteria and found strong immunofluorescence under the induced condition (Figures 6-7).

Figure 6

Figure 6: Uninduced pET26b-INPNC-DARPin-HA (-IPTG) bacteria are not immunostained by anti-HA antibody

Figure 7

Figure 7: Induced pET26b-INPNC-DARPin-HA (+IPTG) bacteria are strongly immunostained by anti-HA antibody, indicating surface expression.

We also repeated the experiment without the antibody to rule out any possibility of autofluore

scence. As expected, no fluorescence was detected when INPNC-DARPin-HA bacteria were not stained with the anti-HA Alexa-Fluor 647 antibody (Figures 8-9).

Figure 8

Figure 8: Uninduced pET26b-INPNC-DARPin-HA (-IPTG) (-AB) bacteria are not fluorescent.

Figure 9

Figure 9: Induced pET26b-INPNC-DARPin-HA (-IPTG) (-AB) bacteria are not fluorescent.

All controls performed as expected, and we are very confident that our DARPin has been displayed on the surface of E. coli.

Retrieved from "http://2012.igem.org/Team:Penn/SurfaceDisplay"

@@ Line 21: / Line 21: @@
 </div></b><br />
 <p style="color:black;text-indent:30px;">
-Having demonstrated that our INPNC surface display system could localize a desired protein (mCherry) to the outer membrane surface, we sought to display the picomolar affinity, HER2 binding Designed Ankyrin Repeat Protein (DARPin) H10-2-G3 on the surface of our BL21 cells. This would allow for bacterial targeting to HER2 over-expressing cells, which could then be lysed in a spatially accurate manner using our light-activated ClyA expression system. Such surface display of a large antibody-mimetic protein is unprecedented, and assaying whether it had actually occurred would be difficult.</p>
+Having demonstrated that our INPNC surface display system could localize a desired protein (mCherry) to the outer membrane surface, we sought to display the picomolar affinity, HER2 binding Designed Ankyrin Repeat Protein (DARPin) H10-2-G3 on the surface of our BL21 cells. This would allow for bacterial targeting to HER2 over-expressing cells, that could then be lysed in a spatially accurate manner using our light-activated ClyA expression system. Such surface display of a large antibody-mimetic protein is unprecedented, and assaying whether it had actually occurred would be difficult.</p>
 <p style="color:black;text-indent:30px;">
-We constructed a C-terminal INPNC-DARPin fusion in the same manner as our INPNC-mCherry fusion, except we added a Human Influenza Aggregation (HA) tag to the N-terminal of DARPin, to allow us to use antibodies to assay whether it had been localized to the membrane. After expression and 48-hour induction of INPNC-DARPin-HA in BL21 cells using the pET26b expression vector, we immunostained cells using an anti-HA, Alexa-fluor 647 conjugated antibody (Cell Signaling Technologies). Since antibodies are not permeable to the E. coli membrane, after washing the cells there should only be signal on those cells which have displayed the HA tag on their surface. We attempted to assay these stained cells with flow cytometry, but soon realized that we required much higher-resolution FACS sorting equipment than we had available to count bacteria.</p>
+We constructed a C-terminal INPNC-DARPin fusion in the same manner as our INPNC-mCherry fusion, except we added a Human Influenza Aggregation (HA) tag to the N-terminal of DARPin to allow us to use antibodies to assay whether it had been localized to the membrane. After expression and 48-hour induction of INPNC-DARPin-HA in BL21 cells using the pET26b expression vector, we immunostained cells using an anti-HA, Alexa-fluor 647 conjugated antibody (Cell Signaling Technologies). Since antibodies are not permeable to the E. coli membrane, after washing the cells there should be signal only on those cells that have displayed the HA tag on their surface. We attempted to assay these stained cells with flow cytometry, but soon realized that we required much higher-resolution FACS sorting equipment than we had available to count bacteria.</p>
 <p style="color:black;text-indent:30px;">
-We then took a small amount of HA immunostained bacteria and visualized them by confocal microscopy at high (630x) magnification using a 633 He-Ne laser. Using this immunostaining visualization method, we were able to demonstrate for the first time that DARPin H10-2-G3 had in fact been localized to the cell surface (Figures 2-9)!</p>
+We then took a small amount of HA immunostained bacteria and visualized them by confocal microscopy at high (630x) magnification using a 633 He-Ne laser. Using this immunostaining visualization method, we were able to demonstrate for the first time that DARPin H10-2-G3 had in fact been localized to the cell surface (Figures 2-9).</p>
 <p style="color:black;text-indent:30px;">
 We first stained control bacteria expressing DARPin-HA without fusion to INPNC (Figures 2-3). The following images were taken of identical densities of bacteria as verified by phase contrast.</p>